| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.694 | 0.005 | 0.694 | Amyloid beta aggregation inhibitor | 0.419 0.022 CID_7515 | ||
| 0.608 | 0.004 | 0.608 | Amyloid beta precursor protein antagonist | 0.431 0.005 CID_7515 | ||
| 0.569 | 0.011 | 0.569 | GABA C receptor rho-3 antagonist | 0.569 0.011 CID_7515 | ||
| 0.562 | 0.013 | 0.637 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.637 0.004 CID_7515 | CID_7515 | |
| 0.568 | 0.023 | 0.568 | Aldehyde oxidase inhibitor | 0.503 0.032 CID_7515 | ||
| 0.553 | 0.025 | 0.553 | Cholesterol antagonist | 0.322 0.078 CID_7515 | ||
| 0.514 | 0.008 | 0.514 | Sigma receptor agonist | 0.216 0.057 CID_7515 | ||
| 0.528 | 0.023 | 0.528 | 5 Hydroxytryptamine release stimulant | 0.497 0.028 CID_7515 | ||
| 0.507 | 0.004 | 0.507 | Lipocortins synthesis antagonist | 0.153 0.1 CID_7515 | ||
| 0.496 | 0.034 | 0.522 | 5 Hydroxytryptamine release inhibitor | 0.522 0.026 CID_7515 | CID_7515 | |
| 0.462 | 0.01 | 0.462 | Anesthetic general | 0.409 0.015 CID_7515 | ||
| 0.43 | 0.017 | 0.503 | Peroxidase inhibitor | 0.503 0.009 CID_7515 | CID_7515 | |
| 0.426 | 0.032 | 0.426 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.326 0.057 CID_7515 | ||
| 0.387 | 0.005 | 0.394 | Gastrin inhibitor | 0.394 0.005 CID_7515 | CID_7515 | |
| 0.431 | 0.059 | 0.534 | Histamine release inhibitor | 0.534 0.019 CID_7515 | CID_7515 | |
| 0.405 | 0.054 | 0.405 | Vasodilator, peripheral | 0.322 0.086 CID_7515 | ||
| 0.44 | 0.088 | 0.447 | Caspase 9 stimulant | 0.447 0.085 CID_7515 | CID_7515 | |
| 0.362 | 0.011 | 0.402 | Alpha-N-acetylglucosaminidase inhibitor | 0.402 0.009 CID_7515 | CID_7515 | |
| 0.37 | 0.02 | 0.371 | 5 Hydroxytryptamine uptake stimulant | 0.371 0.02 CID_7515 | CID_7515 | |
| 0.354 | 0.012 | 0.354 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.273 0.033 CID_7515 | ||
| 0.369 | 0.029 | 0.369 | Sodium/bile acid cotransporter inhibitor | |||
| 0.346 | 0.007 | 0.346 | NADPH oxidase inhibitor | 0.155 0.051 CID_7515 | ||
| 0.336 | 0.005 | 0.383 | Ferrochelatase inhibitor | 0.383 0.004 CID_7515 | CID_7515 | |
| 0.345 | 0.017 | 0.345 | Tyrosine 3 hydroxylase inhibitor | 0.331 0.021 CID_7515 | ||
| 0.385 | 0.068 | 0.758 | MAP kinase kinase 6 inhibitor | 0.758 0.004 CID_7515 | CID_7515 | |
| 0.315 | 0.005 | 0.315 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.338 | 0.029 | 0.338 | Cyclic AMP phosphodiesterase inhibitor | 0.238 0.07 CID_7515 | ||
| 0.311 | 0.005 | 0.311 | Mannose-6-phosphate isomerase inhibitor | 0.224 0.019 CID_7515 | ||
| 0.343 | 0.043 | 0.343 | DNA damaging | 0.297 0.058 CID_7515 | ||
| 0.336 | 0.04 | 0.336 | Insulysin inhibitor | 0.294 0.062 CID_7515 | ||
| 0.327 | 0.035 | 0.327 | DNA synthesis inhibitor | 0.275 0.053 CID_7515 | ||
| 0.342 | 0.055 | 0.424 | Calcium channel activator | 0.424 0.017 CID_7515 | CID_7515 | |
| 0.299 | 0.013 | 0.299 | Toll-Like receptor 9 antagonist | 0.238 0.023 CID_7515 | ||
| 0.29 | 0.006 | 0.29 | 5 Hydroxytryptamine 3E antagonist | 0.287 0.006 CID_7515 | ||
| 0.324 | 0.042 | 0.324 | Pyruvate kinase inhibitor | 0.167 0.102 CID_7515 | ||
| 0.284 | 0.01 | 0.305 | GABA C receptor agonist | 0.305 0.009 CID_7515 | CID_7515 | |
| 0.314 | 0.048 | 0.35 | Transcription factor STAT inhibitor | 0.35 0.034 CID_7515 | CID_7515 | |
| 0.355 | 0.096 | 0.355 | 15-Lipoxygenase inhibitor | 0.355 0.097 CID_7515 | ||
| 0.315 | 0.058 | 0.315 | Hypoxia-inducible factor 1 alpha inhibitor | 0.185 0.171 CID_7515 | ||
| 0.306 | 0.05 | 0.306 | Antiamyloidogenic | 0.289 0.055 CID_7515 | ||
| 0.262 | 0.009 | 0.287 | Ca(v)2.2 blocker | 0.287 0.006 CID_7515 | CID_7515 | |
| 0.309 | 0.058 | 0.309 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.286 0.074 CID_7515 | ||
| 0.273 | 0.024 | 0.273 | Cytidine deaminase inhibitor | 0.174 0.06 CID_7515 | ||
| 0.258 | 0.01 | 0.267 | GABA C receptor rho-2 antagonist | 0.267 0.009 CID_7515 | CID_7515 | |
| 0.286 | 0.04 | 0.31 | MAP kinase kinase 2 inhibitor | 0.31 0.032 CID_7515 | CID_7515 | |
| 0.268 | 0.022 | 0.28 | Nitric-oxide synthase stimulant | 0.28 0.017 CID_7515 | CID_7515 | |
| 0.283 | 0.043 | 0.359 | 5 Hydroxytryptamine 1E antagonist | 0.359 0.008 CID_7515 | CID_7515 | |
| 0.293 | 0.053 | 0.293 | Superoxide dismutase inhibitor | 0.279 0.059 CID_7515 | ||
| 0.24 | 0.008 | 0.24 | CF transmembrane conductance regulator agonist | 0.235 0.009 CID_7515 | ||
| 0.238 | 0.007 | 0.238 | Photosensitizer | 0.143 0.035 CID_7515 | ||
| 0.252 | 0.022 | 0.252 | Succinate dehydrogenase inhibitor | 0.242 0.025 CID_7515 | ||
| 0.268 | 0.04 | 0.268 | Neuropeptide Y2 antagonist | 0.256 0.051 CID_7515 | ||
| 0.277 | 0.049 | 0.277 | Psychostimulant | 0.236 0.064 CID_7515 | ||
| 0.26 | 0.032 | 0.293 | I kappa B kinase epsilon inhibitor | 0.293 0.017 CID_7515 | CID_7515 | |
| 0.25 | 0.025 | 0.25 | Phospholipase C inhibitor | 0.204 0.041 CID_7515 | ||
| 0.261 | 0.043 | 0.365 | RNA-directed DNA polymerase inhibitor | 0.365 0.022 CID_7515 | CID_7515 | |
| 0.233 | 0.019 | 0.233 | Chelator | |||
| 0.251 | 0.037 | 0.268 | Focal adhesion kinase 2 inhibitor | 0.268 0.028 CID_7515 | CID_7515 | |
| 0.257 | 0.046 | 0.279 | Peptidyltransferase inhibitor | 0.279 0.034 CID_7515 | CID_7515 | |
| 0.299 | 0.088 | 0.299 | Vasodilator, coronary | 0.265 0.12 CID_7515 | ||
| 0.215 | 0.005 | 0.215 | Tyrosine-protein kinase EMT inhibitor | 0.121 0.013 CID_7515 | ||
| 0.212 | 0.006 | 0.212 | Transcription factor STAT6 inhibitor | 0.139 0.034 CID_7515 | ||
| 0.211 | 0.008 | 0.211 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.268 | 0.066 | 0.29 | Interleukin agonist | 0.29 0.053 CID_7515 | CID_7515 | |
| 0.221 | 0.023 | 0.221 | ATPase inhibitor | 0.204 0.034 CID_7515 | ||
| 0.228 | 0.033 | 0.228 | Protein kinase stimulant | 0.182 0.049 CID_7515 | ||
| 0.212 | 0.017 | 0.212 | UDP-glucose 4-epimerase inhibitor | 0.184 0.02 CID_7515 | ||
| 0.207 | 0.013 | 0.229 | 5 Hydroxytryptamine 3A agonist | 0.229 0.008 CID_7515 | CID_7515 | |
| 0.238 | 0.044 | 0.46 | MAP kinase kinase 3 inhibitor | 0.46 0.002 CID_7515 | CID_7515 | |
| 0.203 | 0.012 | 0.316 | GABA C receptor antagonist | 0.316 0.004 CID_7515 | CID_7515 | |
| 0.205 | 0.014 | 0.205 | Adenylate kinase inhibitor | 0.172 0.02 CID_7515 | ||
| 0.234 | 0.044 | 0.234 | Insulin sensitizer | 0.174 0.102 CID_7515 | ||
| 0.228 | 0.038 | 0.228 | Histone acetyltransferase inhibitor | 0.22 0.044 CID_7515 | ||
| 0.205 | 0.016 | 0.205 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.16 0.056 CID_7515 | ||
| 0.212 | 0.023 | 0.212 | Arachidonic acid antagonist | 0.189 0.044 CID_7515 | ||
| 0.215 | 0.029 | 0.215 | Neurotensin receptor agonist | 0.168 0.066 CID_7515 | ||
| 0.193 | 0.009 | 0.291 | GABA C receptor rho-1 antagonist | 0.291 0.004 CID_7515 | CID_7515 | |
| 0.299 | 0.115 | 0.299 | Calpain 2 inhibitor | 0.26 0.142 CID_7515 | ||
| 0.199 | 0.017 | 0.212 | Beta amyloid protein antagonist | 0.212 0.013 CID_7515 | CID_7515 | |
| 0.321 | 0.14 | 0.422 | Calcium channel L-type activator | 0.422 0.067 CID_7515 | CID_7515 | |
| 0.189 | 0.011 | 0.189 | Prolactin inhibitor | 0.158 0.019 CID_7515 | ||
| 0.187 | 0.009 | 0.187 | CYP2A6 inhibitor | 0.135 0.021 CID_7515 | ||
| 0.255 | 0.077 | 0.266 | Aryl hydrocarbon receptor agonist | 0.266 0.072 CID_7515 | CID_7515 | |
| 0.182 | 0.005 | 0.182 | Glutamate (mGluR7) agonist | 0.165 0.008 CID_7515 | ||
| 0.227 | 0.05 | 0.227 | LIM domain kinase 1 inhibitor | 0.224 0.052 CID_7515 | ||
| 0.305 | 0.131 | 0.305 | Antibacterial | 0.294 0.14 CID_7515 | ||
| 0.203 | 0.03 | 0.203 | Toll-Like receptor antagonist | 0.163 0.047 CID_7515 | ||
| 0.226 | 0.054 | 0.262 | Neurotrophic factor enhancer | 0.262 0.032 CID_7515 | CID_7515 | |
| 0.184 | 0.013 | 0.184 | Triose-phosphate isomerase inhibitor | 0.166 0.016 CID_7515 | ||
| 0.185 | 0.014 | 0.185 | Porphobilinogen synthase inhibitor | 0.144 0.022 CID_7515 | ||
| 0.204 | 0.033 | 0.204 | Hexokinase inhibitor | 0.189 0.042 CID_7515 | ||
| 0.196 | 0.027 | 0.196 | Glutamate receptor antagonist | 0.139 0.059 CID_7515 | ||
| 0.251 | 0.082 | 0.337 | Transcription factor STAT3 inhibitor | 0.337 0.037 CID_7515 | CID_7515 | |
| 0.2 | 0.032 | 0.2 | Catenin beta inhibitor | 0.181 0.051 CID_7515 | ||
| 0.198 | 0.031 | 0.198 | Cell wall synthesis inhibitor | 0.196 0.032 CID_7515 | ||
| 0.181 | 0.014 | 0.181 | Creatine kinase inhibitor | 0.153 0.023 CID_7515 | ||
| 0.195 | 0.028 | 0.195 | Alkylator | 0.168 0.038 CID_7515 | ||
| 0.169 | 0.002 | 0.169 | Glutamate (mGluR7) antagonist | 0.104 0.009 CID_7515 | ||
| 0.179 | 0.014 | 0.179 | Sphingomyelinase inhibitor | 0.145 0.027 CID_7515 | ||
| 0.21 | 0.046 | 0.21 | 3C-like protease (Human coronavirus) inhibitor | 0.18 0.065 CID_7515 | ||
| 0.174 | 0.01 | 0.174 | Glutamate (mGluR group I) antagonist | 0.078 0.04 CID_7515 | ||
| 0.178 | 0.014 | 0.178 | Nitric-oxide synthase inhibitor | 0.16 0.019 CID_7515 | ||
| 0.273 | 0.111 | 0.273 | Transcription factor NF kappa B inhibitor | 0.262 0.119 CID_7515 | ||
| 0.197 | 0.036 | 0.197 | Nav1.2 sodium channel blocker | 0.144 0.061 CID_7515 | ||
| 0.175 | 0.015 | 0.175 | Folate antagonist | |||
| 0.172 | 0.011 | 0.172 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 CID_7515 | ||
| 0.174 | 0.013 | 0.174 | NADH dehydrogenase inhibitor | 0.152 0.017 CID_7515 | ||
| 0.215 | 0.055 | 0.215 | P-glycoprotein inhibitor | |||
| 0.177 | 0.017 | 0.18 | Gastric antisecretory | 0.18 0.016 CID_7515 | CID_7515 | |
| 0.167 | 0.009 | 0.167 | Histamine N-methyltransferase inhibitor | 0.155 0.012 CID_7515 | ||
| 0.171 | 0.017 | 0.171 | Heat shock protein 70 antagonist | 0.163 0.025 CID_7515 | ||
| 0.316 | 0.163 | 0.316 | MAP kinase 1 inhibitor | 0.289 0.193 CID_7515 | ||
| 0.171 | 0.019 | 0.171 | HIV-1 integrase (Overall Integration) inhibitor | 0.154 0.024 CID_7515 | ||
| 0.181 | 0.029 | 0.181 | Cystathionine beta-synthase inhibitor | 0.163 0.035 CID_7515 | ||
| 0.172 | 0.021 | 0.172 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.159 0.024 CID_7515 | ||
| 0.184 | 0.033 | 0.184 | MAO A inhibitor | 0.145 0.042 CID_7515 | ||
| 0.174 | 0.025 | 0.174 | Calcium channel N-type blocker | 0.145 0.041 CID_7515 | ||
| 0.168 | 0.019 | 0.168 | DNA repair enzyme inhibitor | 0.145 0.036 CID_7515 | ||
| 0.18 | 0.033 | 0.18 | Aldehyde dehydrogenase inhibitor | 0.111 0.082 CID_7515 | ||
| 0.155 | 0.009 | 0.155 | Glutamate release inhibitor | 0.13 0.016 CID_7515 | ||
| 0.234 | 0.088 | 0.272 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.272 0.043 CID_7515 | CID_7515 | |
| 0.163 | 0.018 | 0.163 | Urease inhibitor | 0.139 0.029 CID_7515 | ||
| 0.152 | 0.008 | 0.152 | GABA aminotransferase inhibitor | 0.113 0.019 CID_7515 | ||
| 0.182 | 0.039 | 0.182 | Acetylcholinesterase inhibitor | |||
| 0.147 | 0.004 | 0.147 | GABA B receptor agonist | 0.088 0.028 CID_7515 | ||
| 0.152 | 0.01 | 0.152 | Alcohol oxidase inhibitor | 0.127 0.013 CID_7515 | ||
| 0.152 | 0.016 | 0.152 | Inducible nitric-oxide synthase inhibitor | 0.111 0.029 CID_7515 | ||
| 0.235 | 0.098 | 0.235 | Spasmolytic | 0.195 0.124 CID_7515 | ||
| 0.17 | 0.035 | 0.184 | Adenylate cyclase stimulant | 0.184 0.023 CID_7515 | CID_7515 | |
| 0.168 | 0.035 | 0.168 | MAP kinase kinase 4 inhibitor | 0.138 0.089 CID_7515 | ||
| 0.168 | 0.035 | 0.168 | Cathepsin H inhibitor | 0.16 0.039 CID_7515 | ||
| 0.15 | 0.017 | 0.15 | Glutamate (mGluR) antagonist | |||
| 0.159 | 0.027 | 0.159 | Protein kinase C gamma inhibitor | 0.15 0.031 CID_7515 | ||
| 0.148 | 0.016 | 0.148 | Glutamate dehydrogenase inhibitor | 0.115 0.024 CID_7515 | ||
| 0.179 | 0.048 | 0.179 | MAO inhibitor | 0.146 0.062 CID_7515 | ||
| 0.174 | 0.042 | 0.174 | Calcium channel blocker | 0.142 0.066 CID_7515 | ||
| 0.135 | 0.005 | 0.135 | CC chemokine 5 receptor agonist | 0.108 0.014 CID_7515 | ||
| 0.181 | 0.051 | 0.181 | Acetylcholine M1 receptor antagonist | 0.159 0.067 CID_7515 | ||
| 0.165 | 0.036 | 0.168 | Antibacterial (Helicobacter pylori) | 0.168 0.034 CID_7515 | CID_7515 | |
| 0.15 | 0.02 | 0.15 | Telomerase inhibitor | 0.128 0.024 CID_7515 | ||
| 0.175 | 0.046 | 0.226 | Cytokine production inhibitor | 0.226 0.029 CID_7515 | CID_7515 | |
| 0.169 | 0.041 | 0.17 | Anesthetic local | 0.17 0.041 CID_7515 | CID_7515 | |
| 0.138 | 0.01 | 0.138 | Acyl-CoA dehydrogenase inhibitor | 0.111 0.014 CID_7515 | ||
| 0.166 | 0.039 | 0.166 | Nav1.6 sodium channel blocker | 0.15 0.054 CID_7515 | ||
| 0.165 | 0.038 | 0.204 | Interleukin 4 antagonist | 0.204 0.021 CID_7515 | CID_7515 | |
| 0.133 | 0.006 | 0.133 | Estrogen-related receptor beta agonist | 0.109 0.016 CID_7515 | ||
| 0.207 | 0.083 | 0.232 | EphB2 antagonist | 0.232 0.067 CID_7515 | CID_7515 | |
| 0.147 | 0.023 | 0.147 | Calcium antagonist | 0.111 0.04 CID_7515 | ||
| 0.143 | 0.019 | 0.143 | Thioredoxin inhibitor | |||
| 0.144 | 0.02 | 0.144 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.088 0.044 CID_7515 | ||
| 0.137 | 0.014 | 0.138 | Phosphodiesterase 6D inhibitor | 0.138 0.014 CID_7515 | CID_7515 | |
| 0.158 | 0.035 | 0.185 | Alpha 2b adrenoreceptor antagonist | 0.185 0.027 CID_7515 | CID_7515 | |
| 0.133 | 0.011 | 0.133 | Biliverdin reductase inhibitor | 0.111 0.016 CID_7515 | ||
| 0.129 | 0.009 | 0.129 | Glutamate (mGluR1) antagonist | 0.114 0.012 CID_7515 | ||
| 0.142 | 0.023 | 0.145 | Electrolyte absorption antagonist | 0.145 0.021 CID_7515 | CID_7515 | |
| 0.159 | 0.041 | 0.16 | Cyclooxygenase 3 inhibitor | 0.16 0.04 CID_7515 | CID_7515 | |
| 0.152 | 0.035 | 0.173 | Falcipain 3 inhibitor | 0.173 0.027 CID_7515 | CID_7515 | |
| 0.137 | 0.021 | 0.142 | Phosphofructokinase-1 inhibitor | 0.142 0.02 CID_7515 | CID_7515 | |
| 0.16 | 0.046 | 0.175 | Sphingosine 1-phosphate receptor 5 antagonist | 0.175 0.029 CID_7515 | CID_7515 | |
| 0.151 | 0.037 | 0.151 | Aminopeptidase B inhibitor | 0.139 0.043 CID_7515 | ||
| 0.139 | 0.025 | 0.139 | Acetylcholine release stimulant | 0.121 0.046 CID_7515 | ||
| 0.118 | 0.004 | 0.118 | Corticotropin releasing factor 2 receptor antagonist | 0.074 0.023 CID_7515 | ||
| 0.172 | 0.059 | 0.191 | Cyclin-dependent kinase 8 inhibitor | 0.191 0.042 CID_7515 | CID_7515 | |
| 0.17 | 0.057 | 0.17 | Interferon gamma antagonist | 0.143 0.088 CID_7515 | ||
| 0.138 | 0.026 | 0.138 | Androgen antagonist | 0.123 0.032 CID_7515 | ||
| 0.179 | 0.068 | 0.179 | Mcl-1 antagonist | |||
| 0.171 | 0.061 | 0.171 | Cholinergic | |||
| 0.145 | 0.035 | 0.145 | Mucolytic | 0.118 0.057 CID_7515 | ||
| 0.133 | 0.025 | 0.15 | MAP kinase kinase 1 inhibitor | 0.15 0.016 CID_7515 | CID_7515 | |
| 0.112 | 0.004 | 0.112 | Squalene epoxidase inhibitor | 0.058 0.023 CID_7515 | ||
| 0.115 | 0.01 | 0.144 | Potassium channel (ATP-sensitive) blocker | 0.144 0.005 CID_7515 | CID_7515 | |
| 0.14 | 0.035 | 0.16 | Carbonic anhydrase XV inhibitor | 0.16 0.027 CID_7515 | CID_7515 | |
| 0.111 | 0.006 | 0.111 | MAP kinase kinase 7 inhibitor | 0.104 0.01 CID_7515 | ||
| 0.186 | 0.082 | 0.186 | Non-steroidal antiinflammatory agent | |||
| 0.139 | 0.035 | 0.139 | Nav1.5 sodium channel blocker | |||
| 0.152 | 0.049 | 0.18 | Pregnane X receptor agonist | 0.18 0.019 CID_7515 | CID_7515 | |
| 0.107 | 0.004 | 0.107 | Motilin receptor agonist | |||
| 0.121 | 0.019 | 0.121 | Bile acid receptor antagonist | 0.104 0.04 CID_7515 | ||
| 0.122 | 0.019 | 0.122 | Myeloperoxidase inhibitor | 0.097 0.039 CID_7515 | ||
| 0.142 | 0.04 | 0.142 | GABA receptor agonist | |||
| 0.117 | 0.016 | 0.117 | Carbamoyl phosphate synthetase inhibitor | 0.099 0.021 CID_7515 | ||
| 0.111 | 0.011 | 0.146 | NMDA 2A receptor antagonist | 0.146 0.007 CID_7515 | CID_7515 | |
| 0.272 | 0.172 | 0.272 | Transcription factor inhibitor | 0.261 0.179 CID_7515 | ||
| 0.142 | 0.042 | 0.142 | Microtubule formation inhibitor | 0.127 0.053 CID_7515 | ||
| 0.139 | 0.04 | 0.139 | Calcium channel (voltage-sensitive) blocker | 0.114 0.064 CID_7515 | ||
| 0.141 | 0.042 | 0.163 | Sphingosine 1-phosphate receptor 4 antagonist | 0.163 0.024 CID_7515 | CID_7515 | |
| 0.125 | 0.027 | 0.125 | Potassium channel (Voltage-sensitive) activator | 0.103 0.049 CID_7515 | ||
| 0.172 | 0.075 | 0.172 | Tumour necrosis factor antagonist | 0.154 0.095 CID_7515 | ||
| 0.106 | 0.01 | 0.106 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.106 0.01 CID_7515 | ||
| 0.138 | 0.042 | 0.138 | MAO B inhibitor | 0.092 0.064 CID_7515 | ||
| 0.148 | 0.052 | 0.172 | MAP kinase kinase inhibitor | 0.172 0.04 CID_7515 | CID_7515 | |
| 0.11 | 0.014 | 0.11 | Carbonic anhydrase VB inhibitor | 0.079 0.023 CID_7515 | ||
| 0.115 | 0.02 | 0.115 | Phenylalanine 4-hydroxylase inhibitor | 0.106 0.023 CID_7515 | ||
| 0.132 | 0.037 | 0.195 | Carbonic anhydrase III inhibitor | 0.195 0.017 CID_7515 | CID_7515 | |
| 0.271 | 0.175 | 0.271 | Alpha-glucosidase inhibitor | |||
| 0.144 | 0.049 | 0.163 | Sphingosine 1-phosphate receptor 2 antagonist | 0.163 0.027 CID_7515 | CID_7515 | |
| 0.116 | 0.021 | 0.116 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.144 | 0.049 | 0.22 | Adenylate cyclase inhibitor | 0.22 0.023 CID_7515 | CID_7515 | |
| 0.175 | 0.081 | 0.175 | CDC-like kinase 4 inhibitor | |||
| 0.166 | 0.072 | 0.166 | Heat shock protein 90 alpha antagonist | 0.149 0.088 CID_7515 | ||
| 0.122 | 0.029 | 0.122 | Lanosterol 14 alpha demethylase inhibitor | 0.113 0.039 CID_7515 | ||
| 0.106 | 0.013 | 0.106 | Alpha 2 adrenoreceptor agonist | 0.099 0.015 CID_7515 | ||
| 0.117 | 0.025 | 0.149 | NMDA 2 receptor antagonist | 0.149 0.017 CID_7515 | CID_7515 | |
| 0.114 | 0.022 | 0.114 | Glycine receptor antagonist | 0.108 0.025 CID_7515 | ||
| 0.142 | 0.051 | 0.142 | Histone deacetylase class III inhibitor | 0.111 0.079 CID_7515 | ||
| 0.152 | 0.061 | 0.155 | Neuropeptide Y1 antagonist | 0.155 0.058 CID_7515 | CID_7515 | |
| 0.11 | 0.019 | 0.138 | D-Ala-D-Ala ligase inhibitor | 0.138 0.008 CID_7515 | CID_7515 | |
| 0.104 | 0.013 | 0.104 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.084 0.018 CID_7515 | ||
| 0.112 | 0.022 | 0.112 | Granulocyte macrophage colony stimulating factor agonist | 0.11 0.023 CID_7515 | ||
| 0.132 | 0.042 | 0.132 | Alpha 2c adrenoreceptor antagonist | 0.109 0.058 CID_7515 | ||
| 0.096 | 0.007 | 0.096 | Alpha-mannosidase inhibitor | 0.076 0.013 CID_7515 | ||
| 0.157 | 0.068 | 0.157 | Heat shock protein 90 antagonist | 0.121 0.112 CID_7515 | ||
| 0.115 | 0.026 | 0.115 | Glutathione S-transferase inhibitor | 0.095 0.042 CID_7515 | ||
| 0.115 | 0.026 | 0.131 | Bromodomain-containing protein 2 inhibitor | 0.131 0.017 CID_7515 | CID_7515 | |
| 0.133 | 0.045 | 0.133 | TRPA1 agonist | 0.133 0.045 CID_7515 | ||
| 0.103 | 0.015 | 0.103 | Vanilloid 4 agonist | 0.095 0.021 CID_7515 | ||
| 0.093 | 0.005 | 0.093 | Glutamate (mGluR group III) antagonist | 0.043 0.032 CID_7515 | ||
| 0.153 | 0.066 | 0.153 | Thiol protease inhibitor | 0.124 0.108 CID_7515 | ||
| 0.108 | 0.021 | 0.108 | Caspase 7 inhibitor | 0.102 0.026 CID_7515 | ||
| 0.102 | 0.014 | 0.102 | 5 Hydroxytryptamine 3 agonist | 0.099 0.016 CID_7515 | ||
| 0.126 | 0.039 | 0.126 | DOPA decarboxylase inhibitor | 0.118 0.048 CID_7515 | ||
| 0.103 | 0.016 | 0.132 | Purinergic P2X1 antagonist | 0.132 0.009 CID_7515 | CID_7515 | |
| 0.229 | 0.144 | 0.229 | Antithrombotic | 0.221 0.152 CID_7515 | ||
| 0.182 | 0.097 | 0.182 | Anticonvulsant | 0.175 0.103 CID_7515 | ||
| 0.099 | 0.015 | 0.099 | Androgen agonist | 0.083 0.022 CID_7515 | ||
| 0.109 | 0.024 | 0.112 | mTOR complex 2 inhibitor | 0.112 0.022 CID_7515 | CID_7515 | |
| 0.093 | 0.009 | 0.093 | Transcription factor RelA inhibitor | 0.068 0.034 CID_7515 | ||
| 0.132 | 0.048 | 0.207 | Interleukin 8 antagonist | 0.207 0.011 CID_7515 | CID_7515 | |
| 0.133 | 0.05 | 0.133 | 5 Hydroxytryptamine 2B antagonist | 0.113 0.068 CID_7515 | ||
| 0.224 | 0.141 | 0.224 | Thyroid hormone antagonist | |||
| 0.086 | 0.003 | 0.086 | Protease (Human cytomegalovirus) inhibitor | 0.045 0.005 CID_7515 | ||
| 0.11 | 0.027 | 0.11 | Histamine H2 receptor antagonist | 0.106 0.03 CID_7515 | ||
| 0.121 | 0.039 | 0.121 | Anabolic | 0.116 0.044 CID_7515 | ||
| 0.086 | 0.005 | 0.114 | Diamine oxidase inhibitor | 0.114 0.004 CID_7515 | CID_7515 | |
| 0.135 | 0.054 | 0.135 | Acetylcholine muscarinic antagonist | 0.108 0.081 CID_7515 | ||
| 0.106 | 0.025 | 0.106 | Alpha adrenoreceptor agonist | 0.097 0.029 CID_7515 | ||
| 0.089 | 0.009 | 0.089 | Calcium channel P-type blocker | 0.063 0.047 CID_7515 | ||
| 0.107 | 0.026 | 0.107 | Glutamate decarboxylase inhibitor | 0.096 0.032 CID_7515 | ||
| 0.091 | 0.01 | 0.091 | Aconitate hydratase inhibitor | 0.078 0.014 CID_7515 | ||
| 0.084 | 0.005 | 0.095 | Alpha 1d adrenoreceptor agonist | 0.095 0.004 CID_7515 | CID_7515 | |
| 0.092 | 0.012 | 0.096 | Histone deacetylase SIRT3 inhibitor | 0.096 0.011 CID_7515 | CID_7515 | |
| 0.103 | 0.024 | 0.115 | Carbonic anhydrase VA inhibitor | 0.115 0.019 CID_7515 | CID_7515 | |
| 0.115 | 0.036 | 0.135 | Protein kinase C zeta inhibitor | 0.135 0.025 CID_7515 | CID_7515 | |
| 0.161 | 0.083 | 0.161 | Dual specificity phosphatase inhibitor | 0.131 0.119 CID_7515 | ||
| 0.084 | 0.006 | 0.146 | Dihydropteroate synthase inhibitor | 0.146 0.004 CID_7515 | CID_7515 | |
| 0.122 | 0.044 | 0.122 | Beta glucuronidase inhibitor | 0.106 0.062 CID_7515 | ||
| 0.116 | 0.039 | 0.117 | Interleukin 1 beta converting enzyme inhibitor | 0.117 0.038 CID_7515 | CID_7515 | |
| 0.091 | 0.014 | 0.091 | Exportin-1 inhibitor | 0.077 0.03 CID_7515 | ||
| 0.092 | 0.015 | 0.092 | Potassium channel (Tandem pore domain) blocker | 0.085 0.024 CID_7515 | ||
| 0.094 | 0.017 | 0.094 | Protein kinase C beta inhibitor | 0.086 0.023 CID_7515 | ||
| 0.084 | 0.008 | 0.084 | Mannosidase inhibitor | 0.067 0.013 CID_7515 | ||
| 0.094 | 0.018 | 0.094 | Phospholipase D inhibitor | 0.086 0.026 CID_7515 | ||
| 0.213 | 0.137 | 0.228 | 12-Lipoxygenase inhibitor | 0.228 0.124 CID_7515 | CID_7515 | |
| 0.08 | 0.005 | 0.08 | Endothelial nitric-oxide synthase inhibitor | 0.069 0.006 CID_7515 | ||
| 0.101 | 0.027 | 0.119 | Carbonic anhydrase V inhibitor | 0.119 0.022 CID_7515 | CID_7515 | |
| 0.085 | 0.01 | 0.085 | Histone deacetylase 7 inhibitor | 0.039 0.024 CID_7515 | ||
| 0.085 | 0.01 | 0.085 | Progesterone antagonist | |||
| 0.081 | 0.007 | 0.081 | Cholesterol esterase inhibitor | 0.048 0.033 CID_7515 | ||
| 0.167 | 0.093 | 0.251 | MAP kinase kinase 5 inhibitor | 0.251 0.006 CID_7515 | CID_7515 | |
| 0.084 | 0.011 | 0.092 | Potassium channel (Inward rectifier) blocker | 0.092 0.009 CID_7515 | CID_7515 | |
| 0.087 | 0.015 | 0.087 | Fatty acid synthase inhibitor | 0.051 0.05 CID_7515 | ||
| 0.215 | 0.142 | 0.215 | Thyroid hormone beta antagonist | |||
| 0.1 | 0.029 | 0.1 | Interferon agonist | 0.081 0.051 CID_7515 | ||
| 0.085 | 0.013 | 0.085 | Glucosylceramidase inhibitor | 0.062 0.029 CID_7515 | ||
| 0.079 | 0.008 | 0.079 | Thymidylate synthase inhibitor | 0.055 0.021 CID_7515 | ||
| 0.094 | 0.024 | 0.094 | Acetylcholine M5 receptor agonist | 0.071 0.043 CID_7515 | ||
| 0.09 | 0.02 | 0.135 | NMDA 2C receptor antagonist | 0.135 0.008 CID_7515 | CID_7515 | |
| 0.115 | 0.046 | 0.115 | Insulin receptor antagonist | 0.097 0.066 CID_7515 | ||
| 0.084 | 0.015 | 0.084 | Phosphodiesterase 1A inhibitor | 0.076 0.019 CID_7515 | ||
| 0.073 | 0.005 | 0.073 | Alpha 1L adrenoreceptor agonist | |||
| 0.117 | 0.049 | 0.117 | Butyrylcholinesterase inhibitor | |||
| 0.079 | 0.011 | 0.095 | Dihydroorotate oxidase inhibitor | 0.095 0.005 CID_7515 | CID_7515 | |
| 0.072 | 0.005 | 0.072 | Integrin alpha2 antagonist | 0.051 0.011 CID_7515 | ||
| 0.072 | 0.004 | 0.072 | Kainate receptor agonist | 0.056 0.009 CID_7515 | ||
| 0.097 | 0.03 | 0.097 | Aminopeptidase I inhibitor | 0.088 0.035 CID_7515 | ||
| 0.092 | 0.025 | 0.103 | 5 Hydroxytryptamine 1D antagonist | 0.103 0.021 CID_7515 | CID_7515 | |
| 0.072 | 0.005 | 0.072 | Vascular adhesion protein 1 inhibitor | |||
| 0.075 | 0.008 | 0.075 | Immunoglobulin Fc receptor antagonist | 0.075 0.008 CID_7515 | ||
| 0.079 | 0.013 | 0.079 | 5 Hydroxytryptamine 7 agonist | 0.057 0.037 CID_7515 | ||
| 0.088 | 0.023 | 0.088 | Orexin receptor 1 antagonist | |||
| 0.088 | 0.023 | 0.088 | Argininosuccinate synthase inhibitor | 0.079 0.026 CID_7515 | ||
| 0.076 | 0.011 | 0.076 | Potassium channel small-conductance Ca-activated blocker | 0.045 0.03 CID_7515 | ||
| 0.155 | 0.092 | 0.155 | Dual specificity phosphatase 3 inhibitor | |||
| 0.096 | 0.032 | 0.096 | Histone deacetylase SIRT2 inhibitor | 0.087 0.039 CID_7515 | ||
| 0.086 | 0.022 | 0.086 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.054 0.047 CID_7515 | ||
| 0.095 | 0.032 | 0.095 | Acetylcholine M4 receptor antagonist | |||
| 0.158 | 0.096 | 0.247 | DNA methyltransferase I inhibitor | 0.247 0.048 CID_7515 | CID_7515 | |
| 0.128 | 0.066 | 0.128 | Nav1.3 sodium channel blocker | 0.107 0.089 CID_7515 | ||
| 0.129 | 0.067 | 0.132 | Vanilloid 1 agonist | 0.132 0.063 CID_7515 | CID_7515 | |
| 0.1 | 0.038 | 0.11 | Carbonic anhydrase XIII inhibitor | 0.11 0.033 CID_7515 | CID_7515 | |
| 0.095 | 0.033 | 0.095 | Thioredoxin reductase inhibitor | |||
| 0.116 | 0.054 | 0.116 | Expectorant | 0.092 0.078 CID_7515 | ||
| 0.086 | 0.024 | 0.167 | NMDA receptor glycine site agonist | 0.167 0.004 CID_7515 | CID_7515 | |
| 0.072 | 0.011 | 0.072 | Glucose-6-phosphate isomerase inhibitor | 0.068 0.013 CID_7515 | ||
| 0.09 | 0.029 | 0.09 | 5 Hydroxytryptamine 1B antagonist | 0.073 0.038 CID_7515 | ||
| 0.155 | 0.094 | 0.271 | Death-associated protein kinase 2 inhibitor | 0.271 0.01 CID_7515 | CID_7515 | |
| 0.079 | 0.018 | 0.117 | Potassium channel intermediate-conductance Ca-activated blocker | 0.117 0.005 CID_7515 | CID_7515 | |
| 0.082 | 0.022 | 0.096 | 5 Hydroxytryptamine 6 antagonist | 0.096 0.016 CID_7515 | CID_7515 | |
| 0.093 | 0.033 | 0.093 | Transforming growth factor beta 3 antagonist | |||
| 0.167 | 0.107 | 0.262 | Growth factor agonist | 0.262 0.027 CID_7515 | CID_7515 | |
| 0.07 | 0.011 | 0.07 | Glutamate (mGluR1a) antagonist | 0.062 0.014 CID_7515 | ||
| 0.065 | 0.006 | 0.065 | Histamine H1 receptor agonist | 0.06 0.008 CID_7515 | ||
| 0.2 | 0.14 | 0.2 | Lipoxygenase inhibitor | 0.183 0.159 CID_7515 | ||
| 0.089 | 0.029 | 0.089 | Glycine receptor agonist | 0.077 0.043 CID_7515 | ||
| 0.068 | 0.009 | 0.068 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.098 | 0.04 | 0.134 | Carbonic anhydrase VI inhibitor | 0.134 0.025 CID_7515 | CID_7515 | |
| 0.068 | 0.01 | 0.068 | Histone deacetylase 9 inhibitor | 0.042 0.023 CID_7515 | ||
| 0.094 | 0.036 | 0.106 | Nicotinic alpha4beta2 receptor antagonist | 0.106 0.027 CID_7515 | CID_7515 | |
| 0.103 | 0.045 | 0.107 | Alpha 2 adrenoreceptor antagonist | 0.107 0.043 CID_7515 | CID_7515 | |
| 0.081 | 0.023 | 0.081 | Interferon inducer | 0.065 0.042 CID_7515 | ||
| 0.065 | 0.008 | 0.065 | Dihydrofolate reductase inhibitor | 0.05 0.018 CID_7515 | ||
| 0.094 | 0.037 | 0.094 | Na+ K+ transporting ATPase inhibitor | 0.082 0.049 CID_7515 | ||
| 0.09 | 0.033 | 0.116 | Adenosine A3 receptor antagonist | 0.116 0.019 CID_7515 | CID_7515 | |
| 0.092 | 0.035 | 0.117 | Histidine decarboxylase inhibitor | 0.117 0.026 CID_7515 | CID_7515 | |
| 0.066 | 0.009 | 0.066 | Benzodiazepine antagonist | 0.054 0.02 CID_7515 | ||
| 0.082 | 0.025 | 0.105 | Aryl hydrocarbon receptor antagonist | 0.105 0.012 CID_7515 | CID_7515 | |
| 0.121 | 0.064 | 0.121 | Cholesterol synthesis inhibitor | |||
| 0.185 | 0.129 | 0.185 | Calpain inhibitor | 0.182 0.132 CID_7515 | ||
| 0.069 | 0.013 | 0.069 | Histamine H4 receptor antagonist | 0.067 0.014 CID_7515 | ||
| 0.07 | 0.014 | 0.093 | NMDA receptor subunit 3A antagonist | 0.093 0.009 CID_7515 | CID_7515 | |
| 0.135 | 0.08 | 0.135 | Activin receptor-like kinase 2 inhibitor | 0.127 0.089 CID_7515 | ||
| 0.133 | 0.078 | 0.136 | Aurora-C kinase inhibitor | 0.136 0.071 CID_7515 | CID_7515 | |
| 0.21 | 0.155 | 0.21 | Caspase 3 stimulant | |||
| 0.14 | 0.086 | 0.175 | MAP kinase 3 inhibitor | 0.175 0.038 CID_7515 | CID_7515 | |
| 0.149 | 0.095 | 0.149 | Antipruritic | 0.136 0.112 CID_7515 | ||
| 0.059 | 0.005 | 0.059 | LIM domain kinase 2 inhibitor | 0.041 0.009 CID_7515 | ||
| 0.058 | 0.004 | 0.058 | Integrin alpha2beta1 antagonist | 0.036 0.008 CID_7515 | ||
| 0.115 | 0.061 | 0.115 | DNA intercalator | |||
| 0.072 | 0.018 | 0.082 | Histamine agonist | 0.082 0.013 CID_7515 | CID_7515 | |
| 0.124 | 0.07 | 0.124 | Cholinergic antagonist | 0.102 0.093 CID_7515 | ||
| 0.099 | 0.045 | 0.099 | Phosphodiesterase I inhibitor | 0.097 0.048 CID_7515 | ||
| 0.08 | 0.027 | 0.08 | Orexin receptor antagonist | |||
| 0.059 | 0.006 | 0.059 | Liver X receptor beta antagonist | 0.032 0.017 CID_7515 | ||
| 0.063 | 0.01 | 0.063 | Cytokine production stimulant | 0.051 0.027 CID_7515 | ||
| 0.062 | 0.009 | 0.062 | GABA uptake inhibitor | 0.05 0.016 CID_7515 | ||
| 0.08 | 0.027 | 0.08 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.045 CID_7515 | ||
| 0.085 | 0.033 | 0.086 | Phosphodiesterase VI inhibitor | 0.086 0.033 CID_7515 | CID_7515 | |
| 0.081 | 0.029 | 0.081 | Histone deacetylase inhibitor | 0.062 0.05 CID_7515 | ||
| 0.093 | 0.041 | 0.116 | Catalase inhibitor | 0.116 0.034 CID_7515 | CID_7515 | |
| 0.076 | 0.025 | 0.081 | Cyclin-dependent kinase 6 inhibitor | 0.081 0.021 CID_7515 | CID_7515 | |
| 0.066 | 0.014 | 0.066 | Histone deacetylase 8 inhibitor | 0.047 0.024 CID_7515 | ||
| 0.073 | 0.022 | 0.073 | Botulinum neurotoxin type A inhibitor | 0.062 0.035 CID_7515 | ||
| 0.056 | 0.005 | 0.056 | CF transmembrane conductance regulator antagonist | 0.041 0.023 CID_7515 | ||
| 0.104 | 0.052 | 0.165 | Potassium channel (Ca-activated) activator | 0.165 0.023 CID_7515 | CID_7515 | |
| 0.121 | 0.07 | 0.121 | Acetylcholine antagonist | 0.101 0.092 CID_7515 | ||
| 0.057 | 0.007 | 0.057 | Protein 30S ribosomal subunit inhibitor | |||
| 0.078 | 0.027 | 0.078 | Glutamate (mGluR6) antagonist | 0.078 0.027 CID_7515 | ||
| 0.06 | 0.01 | 0.06 | Farnesoid X receptor agonist | |||
| 0.096 | 0.045 | 0.107 | Bcr-Abl kinase inhibitor | 0.107 0.035 CID_7515 | CID_7515 | |
| 0.116 | 0.066 | 0.12 | Caspase 3 inhibitor | 0.12 0.061 CID_7515 | CID_7515 | |
| 0.079 | 0.03 | 0.079 | MAP kinase kinase 10 inhibitor | |||
| 0.067 | 0.017 | 0.067 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.062 | 0.013 | 0.062 | Dopamine beta hydroxylase inhibitor | 0.054 0.023 CID_7515 | ||
| 0.067 | 0.018 | 0.067 | Pregnane X receptor antagonist | 0.057 0.038 CID_7515 | ||
| 0.067 | 0.018 | 0.067 | Topoisomerase II beta inhibitor | 0.065 0.019 CID_7515 | ||
| 0.055 | 0.006 | 0.055 | CDK4/cyclin D3 inhibitor | 0.029 0.019 CID_7515 | ||
| 0.06 | 0.011 | 0.06 | Guanylate cyclase inhibitor | 0.041 0.032 CID_7515 | ||
| 0.062 | 0.013 | 0.062 | Glutamate (mGluR4) antagonist | 0.045 0.027 CID_7515 | ||
| 0.056 | 0.008 | 0.056 | Heme oxygenase inhibitor | 0.041 0.038 CID_7515 | ||
| 0.092 | 0.044 | 0.111 | Acetylcholine nicotinic agonist | 0.111 0.03 CID_7515 | CID_7515 | |
| 0.082 | 0.034 | 0.085 | Secretase beta inhibitor | 0.085 0.03 CID_7515 | CID_7515 | |
| 0.083 | 0.037 | 0.083 | Benzodiazepine agonist | 0.066 0.057 CID_7515 | ||
| 0.06 | 0.014 | 0.06 | AICAR transformylase inhibitor | 0.052 0.02 CID_7515 | ||
| 0.072 | 0.026 | 0.106 | Cyclin H inhibitor | 0.106 0.006 CID_7515 | CID_7515 | |
| 0.055 | 0.01 | 0.081 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.081 0.004 CID_7515 | CID_7515 | |
| 0.051 | 0.006 | 0.051 | Methionyl aminopeptidase 1 inhibitor | 0.041 0.011 CID_7515 | ||
| 0.099 | 0.054 | 0.117 | Alcohol dehydrogenase inhibitor | 0.117 0.037 CID_7515 | CID_7515 | |
| 0.065 | 0.02 | 0.071 | H+/K+-transporting ATPase inhibitor | 0.071 0.017 CID_7515 | CID_7515 | |
| 0.178 | 0.134 | 0.178 | Immunostimulant | 0.178 0.134 CID_7515 | ||
| 0.254 | 0.21 | 0.254 | Apoptosis agonist | |||
| 0.094 | 0.051 | 0.094 | Ornithine decarboxylase inhibitor | 0.077 0.071 CID_7515 | ||
| 0.072 | 0.029 | 0.072 | Acetylcholine M5 receptor antagonist | 0.059 0.043 CID_7515 | ||
| 0.047 | 0.004 | 0.047 | Glucosylceramidase stimulant | 0.045 0.004 CID_7515 | ||
| 0.056 | 0.012 | 0.058 | Nerve growth factor antagonist | 0.058 0.011 CID_7515 | CID_7515 | |
| 0.046 | 0.004 | 0.046 | Estrogen-related receptor gamma antagonist | 0.036 0.008 CID_7515 | ||
| 0.057 | 0.014 | 0.057 | Liver X receptor alpha agonist | |||
| 0.052 | 0.01 | 0.094 | Potassium channel small-conductance Ca-activated activator | 0.094 0.004 CID_7515 | CID_7515 | |
| 0.105 | 0.062 | 0.105 | Toll-Like receptor 4 antagonist | |||
| 0.062 | 0.019 | 0.07 | CXC chemokine 1 receptor antagonist | 0.07 0.013 CID_7515 | CID_7515 | |
| 0.095 | 0.053 | 0.148 | Potassium channel activator | 0.148 0.021 CID_7515 | CID_7515 | |
| 0.07 | 0.028 | 0.07 | Calcium channel T-type blocker | |||
| 0.079 | 0.037 | 0.084 | Sphingosine 1-phosphate receptor 4 agonist | 0.084 0.034 CID_7515 | CID_7515 | |
| 0.057 | 0.016 | 0.061 | Geranyltranstransferase inhibitor | 0.061 0.013 CID_7515 | CID_7515 | |
| 0.105 | 0.064 | 0.105 | AMP-activated protein kinase stimulant | |||
| 0.059 | 0.018 | 0.073 | Adenylate cyclase 1 inhibitor | 0.073 0.011 CID_7515 | CID_7515 | |
| 0.049 | 0.008 | 0.059 | Protein kinase (CK2) beta inhibitor | 0.059 0.005 CID_7515 | CID_7515 | |
| 0.064 | 0.024 | 0.064 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.092 | 0.052 | 0.168 | Stem cell growth factor agonist | 0.168 0.015 CID_7515 | CID_7515 | |
| 0.112 | 0.072 | 0.112 | Proteasome inhibitor | |||
| 0.065 | 0.025 | 0.065 | Ryanodine receptor antagonist | 0.062 0.032 CID_7515 | ||
| 0.127 | 0.088 | 0.127 | Farnesoid X receptor antagonist | |||
| 0.073 | 0.033 | 0.196 | NMDA receptor agonist | 0.196 0.005 CID_7515 | CID_7515 | |
| 0.099 | 0.06 | 0.099 | Platelet activating factor alpha antagonist | |||
| 0.064 | 0.024 | 0.064 | Epithelial sodium channel blocker | 0.058 0.031 CID_7515 | ||
| 0.056 | 0.017 | 0.062 | Histamine H2 receptor agonist | 0.062 0.014 CID_7515 | CID_7515 | |
| 0.069 | 0.029 | 0.069 | Heat shock protein 90 beta antagonist | 0.057 0.046 CID_7515 | ||
| 0.153 | 0.114 | 0.234 | DNA methylase inhibitor | 0.234 0.058 CID_7515 | CID_7515 | |
| 0.053 | 0.014 | 0.053 | Potassium channel KCNQ activator | 0.034 0.029 CID_7515 | ||
| 0.053 | 0.014 | 0.053 | Delayed rectifier potassium channel activator | 0.034 0.029 CID_7515 | ||
| 0.047 | 0.009 | 0.047 | Bradykinin B2 receptor antagonist | |||
| 0.07 | 0.032 | 0.07 | Acetylcholine M3 receptor antagonist | |||
| 0.09 | 0.052 | 0.09 | 5 Hydroxytryptamine 2C antagonist | 0.084 0.057 CID_7515 | ||
| 0.042 | 0.004 | 0.042 | Ileal bile acid transport inhibitor | 0.015 0.014 CID_7515 | ||
| 0.069 | 0.031 | 0.069 | Dopamine uptake inhibitor | 0.056 0.042 CID_7515 | ||
| 0.062 | 0.024 | 0.073 | Nicotinic alpha3beta2 receptor antagonist | 0.073 0.016 CID_7515 | CID_7515 | |
| 0.053 | 0.015 | 0.054 | Dopamine D5 agonist | 0.054 0.015 CID_7515 | CID_7515 | |
| 0.064 | 0.027 | 0.064 | Acetyl-CoA transferase inhibitor | |||
| 0.063 | 0.026 | 0.075 | Nicotinic receptor alpha7 subunit antagonist | 0.075 0.019 CID_7515 | CID_7515 | |
| 0.146 | 0.11 | 0.146 | Platelet adhesion inhibitor | |||
| 0.044 | 0.008 | 0.044 | Liver X receptor alpha antagonist | |||
| 0.071 | 0.035 | 0.071 | MDM2 inhibitor | 0.065 0.055 CID_7515 | ||
| 0.04 | 0.004 | 0.04 | Alpha 2a adrenoreceptor agonist | 0.038 0.004 CID_7515 | ||
| 0.07 | 0.035 | 0.07 | Adrenaline uptake inhibitor | |||
| 0.085 | 0.049 | 0.11 | T cell inhibitor | 0.11 0.018 CID_7515 | CID_7515 | |
| 0.046 | 0.011 | 0.046 | Liver X receptor antagonist | |||
| 0.063 | 0.028 | 0.063 | MAP kinase kinase 9 inhibitor | 0.057 0.037 CID_7515 | ||
| 0.043 | 0.008 | 0.045 | Adenosine uptake inhibitor | 0.045 0.006 CID_7515 | CID_7515 | |
| 0.055 | 0.021 | 0.057 | Fructose-1,6-bisphosphatase inhibitor | 0.057 0.019 CID_7515 | CID_7515 | |
| 0.047 | 0.013 | 0.049 | Glutamate (mGluR8) agonist | 0.049 0.012 CID_7515 | CID_7515 | |
| 0.116 | 0.082 | 0.123 | Toll-Like receptor 2 antagonist | 0.123 0.075 CID_7515 | CID_7515 | |
| 0.041 | 0.007 | 0.046 | Nicotinic alpha4beta2 receptor agonist | 0.046 0.005 CID_7515 | CID_7515 | |
| 0.081 | 0.047 | 0.081 | Alpha 2a adrenoreceptor antagonist | 0.07 0.057 CID_7515 | ||
| 0.041 | 0.007 | 0.041 | Adenosine kinase inhibitor | 0.023 0.014 CID_7515 | ||
| 0.094 | 0.061 | 0.102 | Toll-Like receptor 3 antagonist | 0.102 0.048 CID_7515 | CID_7515 | |
| 0.067 | 0.034 | 0.097 | 5 Hydroxytryptamine 5A antagonist | 0.097 0.017 CID_7515 | CID_7515 | |
| 0.128 | 0.096 | 0.128 | Diuretic | 0.119 0.106 CID_7515 | ||
| 0.066 | 0.034 | 0.08 | Cyclin D1 inhibitor | 0.08 0.018 CID_7515 | CID_7515 | |
| 0.118 | 0.086 | 0.25 | Protein-tyrosine kinase Lyn inhibitor | 0.25 0.029 CID_7515 | CID_7515 | |
| 0.08 | 0.048 | 0.08 | Estrogen receptor alpha antagonist | |||
| 0.044 | 0.012 | 0.044 | Ceramide glucosyltransferase inhibitor | |||
| 0.041 | 0.01 | 0.041 | Nicotinic alpha3beta4 receptor agonist | 0.035 0.014 CID_7515 | ||
| 0.053 | 0.022 | 0.089 | CDK7/cyclin H inhibitor | 0.089 0.007 CID_7515 | CID_7515 | |
| 0.087 | 0.057 | 0.123 | NMDA receptor antagonist | 0.123 0.034 CID_7515 | CID_7515 | |
| 0.075 | 0.045 | 0.075 | Calcium channel L-type blocker | |||
| 0.043 | 0.013 | 0.043 | Liver X receptor beta agonist | |||
| 0.056 | 0.026 | 0.056 | Antiviral (Hepatitis D) | |||
| 0.07 | 0.04 | 0.07 | Dopamine D1 antagonist | 0.058 0.052 CID_7515 | ||
| 0.038 | 0.008 | 0.042 | MAP3K8 inhibitor | 0.042 0.006 CID_7515 | CID_7515 | |
| 0.082 | 0.053 | 0.085 | Acetylcholine nicotinic antagonist | 0.085 0.049 CID_7515 | CID_7515 | |
| 0.045 | 0.016 | 0.045 | Fumarate hydratase inhibitor | 0.035 0.023 CID_7515 | ||
| 0.09 | 0.061 | 0.119 | Polo-like kinase-1 inhibitor | 0.119 0.031 CID_7515 | CID_7515 | |
| 0.047 | 0.018 | 0.047 | Membrane dipeptidase inhibitor | 0.041 0.026 CID_7515 | ||
| 0.051 | 0.023 | 0.075 | Glutamate (mGluR group III) agonist | 0.075 0.014 CID_7515 | CID_7515 | |
| 0.095 | 0.068 | 0.128 | Cyclin-dependent kinase 9 inhibitor | 0.128 0.042 CID_7515 | CID_7515 | |
| 0.031 | 0.004 | 0.031 | Estrogen-related receptor gamma agonist | 0.019 0.012 CID_7515 | ||
| 0.065 | 0.038 | 0.065 | Phosphodiesterase 1C inhibitor | |||
| 0.036 | 0.009 | 0.036 | Purinergic P2Y15 antagonist | 0.036 0.009 CID_7515 | ||
| 0.044 | 0.017 | 0.044 | Retinoid X alpha receptor agonist | 0.034 0.025 CID_7515 | ||
| 0.031 | 0.005 | 0.031 | Alpha 2c adrenoreceptor agonist | 0.028 0.005 CID_7515 | ||
| 0.042 | 0.016 | 0.042 | Sirtuin 2 inhibitor | 0.03 0.026 CID_7515 | ||
| 0.057 | 0.032 | 0.067 | Lysine-specific demethylase 1A inhibitor | 0.067 0.02 CID_7515 | CID_7515 | |
| 0.115 | 0.089 | 0.179 | Cyclin-dependent kinase 7 inhibitor | 0.179 0.043 CID_7515 | CID_7515 | |
| 0.078 | 0.053 | 0.078 | Viral attachment inhibitor | |||
| 0.034 | 0.008 | 0.039 | Hedgehog signaling activator | 0.039 0.005 CID_7515 | CID_7515 | |
| 0.061 | 0.035 | 0.07 | Alpha 1 adrenoreceptor agonist | 0.07 0.028 CID_7515 | CID_7515 | |
| 0.063 | 0.038 | 0.092 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.092 0.013 CID_7515 | CID_7515 | |
| 0.074 | 0.049 | 0.074 | Cathepsin G inhibitor | |||
| 0.057 | 0.033 | 0.057 | Ornithine carbamoyltransferase inhibitor | 0.054 0.036 CID_7515 | ||
| 0.058 | 0.034 | 0.058 | Sphingosine kinase 2 inhibitor | 0.056 0.037 CID_7515 | ||
| 0.046 | 0.022 | 0.046 | Thymidine kinase inhibitor | 0.044 0.024 CID_7515 | ||
| 0.034 | 0.01 | 0.034 | 5 Hydroxytryptamine 1F agonist | |||
| 0.062 | 0.038 | 0.074 | Carbonic anhydrase stimulant | 0.074 0.029 CID_7515 | CID_7515 | |
| 0.026 | 0.003 | 0.026 | Antibiotic Tetracycline-like | |||
| 0.037 | 0.014 | 0.042 | Epoxide hydrolase 1 inhibitor | 0.042 0.01 CID_7515 | CID_7515 | |
| 0.062 | 0.04 | 0.062 | Beta 2 adrenoreceptor agonist | 0.061 0.045 CID_7515 | ||
| 0.049 | 0.026 | 0.091 | Purinergic P2X4 antagonist | 0.091 0.005 CID_7515 | CID_7515 | |
| 0.07 | 0.048 | 0.079 | ZAP-70 protein tyrosine kinase inhibitor | 0.079 0.036 CID_7515 | CID_7515 | |
| 0.043 | 0.021 | 0.043 | Retinoid X receptor agonist | |||
| 0.042 | 0.02 | 0.042 | Retinoid X receptor antagonist | |||
| 0.076 | 0.054 | 0.087 | Keratolytic | 0.087 0.041 CID_7515 | CID_7515 | |
| 0.056 | 0.034 | 0.056 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.051 0.041 CID_7515 | ||
| 0.031 | 0.009 | 0.031 | Vanilloid 2 agonist | 0.028 0.013 CID_7515 | ||
| 0.059 | 0.038 | 0.091 | 5 Hydroxytryptamine 5 antagonist | 0.091 0.017 CID_7515 | CID_7515 | |
| 0.103 | 0.081 | 0.123 | Interleukin 2 antagonist | 0.123 0.041 CID_7515 | CID_7515 | |
| 0.07 | 0.049 | 0.07 | CXC chemokine receptor antagonist | |||
| 0.049 | 0.028 | 0.049 | CC chemokine 4 receptor antagonist | 0.046 0.034 CID_7515 | ||
| 0.033 | 0.013 | 0.035 | 5 Hydroxytryptamine 6 agonist | 0.035 0.011 CID_7515 | CID_7515 | |
| 0.03 | 0.009 | 0.038 | Acid ceramidase inhibitor | 0.038 0.005 CID_7515 | CID_7515 | |
| 0.055 | 0.035 | 0.055 | Protein 50S ribosomal subunit inhibitor | |||
| 0.055 | 0.035 | 0.055 | GABA A receptor antagonist | |||
| 0.04 | 0.019 | 0.04 | Glucocorticoid antagonist | |||
| 0.035 | 0.015 | 0.035 | Cyclin E2 inhibitor | |||
| 0.047 | 0.027 | 0.108 | NMDA receptor subunit 3B antagonist | 0.108 0.01 CID_7515 | CID_7515 | |
| 0.086 | 0.065 | 0.093 | Pim-3 kinase inhibitor | 0.093 0.054 CID_7515 | CID_7515 | |
| 0.044 | 0.023 | 0.044 | Histone deacetylase class I inhibitor | |||
| 0.079 | 0.059 | 0.216 | TIE-2 antagonist | 0.216 0.013 CID_7515 | CID_7515 | |
| 0.038 | 0.018 | 0.038 | Retinoid X alpha receptor antagonist | |||
| 0.076 | 0.056 | 0.076 | Macrophage migration inhibitory factor inhibitor | |||
| 0.053 | 0.033 | 0.053 | 5 Hydroxytryptamine 4 antagonist | 0.048 0.041 CID_7515 | ||
| 0.079 | 0.06 | 0.222 | TIE antagonist | 0.222 0.013 CID_7515 | CID_7515 | |
| 0.042 | 0.022 | 0.042 | Protein kinase (CK1) epsilon inhibitor | 0.042 0.022 CID_7515 | ||
| 0.045 | 0.025 | 0.045 | Angiotensin AT1 receptor antagonist | |||
| 0.141 | 0.121 | 0.141 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.082 | 0.063 | 0.085 | Acetylcholine agonist | 0.085 0.06 CID_7515 | CID_7515 | |
| 0.023 | 0.004 | 0.023 | Human herpes virus 5 capsid protein P40 inhibitor | 0.013 0.009 CID_7515 | ||
| 0.084 | 0.065 | 0.086 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.086 0.062 CID_7515 | CID_7515 | |
| 0.041 | 0.023 | 0.042 | 5 Hydroxytryptamine 2B agonist | 0.042 0.022 CID_7515 | CID_7515 | |
| 0.027 | 0.008 | 0.027 | Glutaminyl-peptide cyclotransferase inhibitor | 0.025 0.01 CID_7515 | ||
| 0.039 | 0.02 | 0.048 | Phosphoglycerate kinase inhibitor | 0.048 0.015 CID_7515 | CID_7515 | |
| 0.049 | 0.031 | 0.067 | Adenosine deaminase inhibitor | 0.067 0.016 CID_7515 | CID_7515 | |
| 0.041 | 0.022 | 0.041 | Factor XIIIa inhibitor | 0.036 0.028 CID_7515 | ||
| 0.036 | 0.018 | 0.036 | Histone deacetylase 10 inhibitor | |||
| 0.031 | 0.012 | 0.031 | Myristoyl transferase inhibitor | 0.025 0.023 CID_7515 | ||
| 0.069 | 0.05 | 0.069 | Amidase inhibitor | |||
| 0.055 | 0.037 | 0.055 | GABA receptor antagonist | |||
| 0.09 | 0.072 | 0.128 | Protein kinase (CK2) inhibitor | 0.128 0.043 CID_7515 | CID_7515 | |
| 0.061 | 0.043 | 0.061 | Acetylcholine M2 receptor antagonist | |||
| 0.058 | 0.04 | 0.058 | Adenosine A1 receptor antagonist | 0.053 0.045 CID_7515 | ||
| 0.064 | 0.046 | 0.064 | Neutrophil collagenase inhibitor | |||
| 0.036 | 0.018 | 0.036 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.051 | 0.033 | 0.078 | Potassium channel (Inward rectifier) activator | 0.078 0.008 CID_7515 | CID_7515 | |
| 0.028 | 0.011 | 0.028 | Complement factor 1s inhibitor | 0.028 0.01 CID_7515 | ||
| 0.055 | 0.038 | 0.055 | Maillard reaction inhibitor | |||
| 0.066 | 0.048 | 0.072 | Neuronal nicotinic receptor antagonist | 0.072 0.043 CID_7515 | CID_7515 | |
| 0.039 | 0.022 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.037 | 0.02 | 0.037 | Free fatty acid receptor 1 antagonist | |||
| 0.051 | 0.034 | 0.059 | Lysophosphatidic acid 3 receptor antagonist | 0.059 0.023 CID_7515 | CID_7515 | |
| 0.041 | 0.024 | 0.049 | MAP3K5 inhibitor | 0.049 0.013 CID_7515 | CID_7515 | |
| 0.039 | 0.023 | 0.057 | Inosine monophosphate dehydrogenase inhibitor | 0.057 0.011 CID_7515 | CID_7515 | |
| 0.039 | 0.022 | 0.039 | Orexin receptor 2 antagonist | |||
| 0.039 | 0.023 | 0.039 | Delayed rectifier potassium channel blocker | 0.038 0.024 CID_7515 | ||
| 0.049 | 0.032 | 0.075 | Potassium channel (ATP-sensitive) activator | 0.075 0.008 CID_7515 | CID_7515 | |
| 0.063 | 0.047 | 0.071 | Beta 3 adrenoreceptor antagonist | 0.071 0.032 CID_7515 | CID_7515 | |
| 0.029 | 0.013 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.016 CID_7515 | ||
| 0.024 | 0.009 | 0.024 | Histamine H4 receptor agonist | 0.02 0.012 CID_7515 | ||
| 0.053 | 0.037 | 0.058 | Heparanase inhibitor | 0.058 0.026 CID_7515 | CID_7515 | |
| 0.14 | 0.124 | 0.14 | Clk dual-specificity kinase inhibitor | |||
| 0.035 | 0.02 | 0.035 | Melatonin receptor 1A agonist | |||
| 0.024 | 0.009 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.01 CID_7515 | ||
| 0.081 | 0.066 | 0.081 | Insulin growth factor antagonist | |||
| 0.054 | 0.039 | 0.054 | Acetylcholine muscarinic agonist | |||
| 0.02 | 0.005 | 0.02 | CDK2/cyclin A3 inhibitor | 0.016 0.013 CID_7515 | ||
| 0.067 | 0.052 | 0.067 | Syk tyrosine kinase inhibitor | 0.064 0.055 CID_7515 | ||
| 0.064 | 0.05 | 0.095 | 5 Hydroxytryptamine 3A antagonist | 0.095 0.019 CID_7515 | CID_7515 | |
| 0.031 | 0.017 | 0.031 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.028 0.019 CID_7515 | ||
| 0.072 | 0.058 | 0.072 | Analgesic, opioid | |||
| 0.043 | 0.029 | 0.043 | Leukocyte elastase inhibitor | |||
| 0.054 | 0.04 | 0.057 | Carbonic anhydrase IX inhibitor | 0.057 0.039 CID_7515 | CID_7515 | |
| 0.047 | 0.034 | 0.047 | Antimetabolite | |||
| 0.076 | 0.063 | 0.082 | Adrenaline agonist | 0.082 0.055 CID_7515 | CID_7515 | |
| 0.042 | 0.029 | 0.042 | Cholecystokinin antagonist | 0.035 0.032 CID_7515 | ||
| 0.023 | 0.01 | 0.027 | Factor XIII inhibitor | 0.027 0.005 CID_7515 | CID_7515 | |
| 0.023 | 0.01 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.077 | 0.065 | 0.077 | Insulin like growth factor 1 antagonist | |||
| 0.043 | 0.03 | 0.043 | Liver X receptor agonist | |||
| 0.049 | 0.037 | 0.049 | Prolyl endopeptidase inhibitor | |||
| 0.023 | 0.011 | 0.023 | Apolipoprotein B inhibitor | 0.018 0.016 CID_7515 | ||
| 0.111 | 0.099 | 0.117 | Alkaline phosphatase inhibitor | 0.117 0.09 CID_7515 | CID_7515 | |
| 0.085 | 0.073 | 0.085 | Protein kinase C mu inhibitor | 0.081 0.079 CID_7515 | ||
| 0.053 | 0.041 | 0.059 | Carbonic anhydrase II inhibitor | 0.059 0.035 CID_7515 | CID_7515 | |
| 0.021 | 0.009 | 0.021 | Antibiotic Anthracycline-like | 0.02 0.01 CID_7515 | ||
| 0.042 | 0.03 | 0.042 | Oxytocin agonist | 0.041 0.03 CID_7515 | ||
| 0.032 | 0.02 | 0.032 | Cholesterol ester transfer protein antagonist | |||
| 0.035 | 0.023 | 0.035 | Angiotensin II receptor antagonist | |||
| 0.017 | 0.005 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.016 0.006 CID_7515 | ||
| 0.104 | 0.093 | 0.104 | Amylase inhibitor | 0.104 0.093 CID_7515 | ||
| 0.021 | 0.01 | 0.026 | Cyclin T1 inhibitor | 0.026 0.007 CID_7515 | CID_7515 | |
| 0.046 | 0.035 | 0.046 | Aldosterone antagonist | 0.046 0.036 CID_7515 | ||
| 0.087 | 0.076 | 0.087 | Xanthine oxidase inhibitor | |||
| 0.04 | 0.03 | 0.04 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.027 | 0.017 | 0.034 | CXC chemokine 2 receptor antagonist | 0.034 0.011 CID_7515 | CID_7515 | |
| 0.128 | 0.118 | 0.131 | Melanin inhibitor | 0.131 0.112 CID_7515 | CID_7515 | |
| 0.018 | 0.008 | 0.025 | NMDA receptor phencyclidine site antagonist | 0.025 0.005 CID_7515 | CID_7515 | |
| 0.022 | 0.012 | 0.029 | Imidazoline I1 receptor antagonist | 0.029 0.008 CID_7515 | CID_7515 | |
| 0.037 | 0.027 | 0.06 | Potassium channel Kv1.1 blocker | 0.06 0.009 CID_7515 | CID_7515 | |
| 0.029 | 0.019 | 0.04 | 5 Hydroxytryptamine 1D agonist | 0.04 0.014 CID_7515 | CID_7515 | |
| 0.088 | 0.078 | 0.134 | MAP kinase kinase kinase inhibitor | 0.134 0.043 CID_7515 | CID_7515 | |
| 0.044 | 0.034 | 0.044 | Glutamate (mGluR5) agonist | |||
| 0.103 | 0.093 | 0.132 | Epidermal growth factor receptor kinase inhibitor | 0.132 0.062 CID_7515 | CID_7515 | |
| 0.075 | 0.066 | 0.075 | Neuropeptide Y antagonist | 0.074 0.07 CID_7515 | ||
| 0.057 | 0.048 | 0.066 | Carbonic anhydrase inhibitor | 0.066 0.042 CID_7515 | CID_7515 | |
| 0.024 | 0.015 | 0.024 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.034 | 0.025 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.028 | 0.019 | 0.028 | Motilin receptor antagonist | |||
| 0.077 | 0.069 | 0.077 | GABA A receptor agonist | |||
| 0.122 | 0.114 | 0.122 | Phospholipase A2 inhibitor | |||
| 0.019 | 0.011 | 0.019 | Apolipoprotein B-100 inhibitor | |||
| 0.067 | 0.058 | 0.092 | MAP kinase 11 inhibitor | 0.092 0.04 CID_7515 | CID_7515 | |
| 0.067 | 0.058 | 0.112 | Epoxide hydrolase inhibitor | 0.112 0.019 CID_7515 | CID_7515 | |
| 0.092 | 0.084 | 0.116 | Protein kinase (CK2) alpha inhibitor | 0.116 0.065 CID_7515 | CID_7515 | |
| 0.03 | 0.023 | 0.03 | Histone deacetylase 11 inhibitor | |||
| 0.03 | 0.023 | 0.03 | Histone deacetylase class IV inhibitor | |||
| 0.064 | 0.056 | 0.064 | Elastase 1 inhibitor | |||
| 0.048 | 0.04 | 0.048 | Carbonic anhydrase XII inhibitor | 0.048 0.04 CID_7515 | ||
| 0.043 | 0.036 | 0.067 | Glycine transporter 2 inhibitor | 0.067 0.022 CID_7515 | CID_7515 | |
| 0.035 | 0.027 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.023 CID_7515 | CID_7515 | |
| 0.017 | 0.009 | 0.017 | Purinergic P2Y1 agonist | 0.016 0.009 CID_7515 | ||
| 0.029 | 0.022 | 0.029 | Peptide deformylase inhibitor | 0.027 0.025 CID_7515 | ||
| 0.05 | 0.043 | 0.05 | Carbonic anhydrase I inhibitor | 0.048 0.045 CID_7515 | ||
| 0.048 | 0.041 | 0.048 | 5 Hydroxytryptamine 2 agonist | 0.045 0.044 CID_7515 | ||
| 0.026 | 0.019 | 0.026 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 CID_7515 | ||
| 0.029 | 0.023 | 0.029 | Acetylcholine M4 receptor agonist | |||
| 0.014 | 0.008 | 0.014 | Cyclin D2 inhibitor | 0.013 0.011 CID_7515 | ||
| 0.09 | 0.084 | 0.09 | Monophenol monooxygenase inhibitor | |||
| 0.018 | 0.012 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.027 | 0.021 | 0.027 | Uridine phosphorylase inhibitor | |||
| 0.024 | 0.019 | 0.025 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 CID_7515 | CID_7515 | |
| 0.023 | 0.017 | 0.023 | ICAM 1 antagonist | |||
| 0.011 | 0.005 | 0.011 | Progesterone receptor A antagonist | |||
| 0.056 | 0.05 | 0.088 | Potassium channel (Ca-activated) blocker | 0.088 0.014 CID_7515 | CID_7515 | |
| 0.043 | 0.038 | 0.043 | Sigma receptor antagonist | |||
| 0.039 | 0.034 | 0.039 | Acetylcholine M1 receptor agonist | |||
| 0.037 | 0.032 | 0.037 | CC chemokine 3 receptor antagonist | |||
| 0.043 | 0.038 | 0.043 | AMPA receptor antagonist | |||
| 0.016 | 0.011 | 0.016 | Nicotinic alpha4 receptor agonist | 0.015 0.013 CID_7515 | ||
| 0.106 | 0.102 | 0.106 | Sodium channel (voltage-gated) blocker | |||
| 0.019 | 0.014 | 0.029 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.029 0.008 CID_7515 | CID_7515 | |
| 0.017 | 0.013 | 0.017 | CXC chemokine 5 receptor antagonist | |||
| 0.016 | 0.012 | 0.021 | Carbonic anhydrase VIII inhibitor | 0.021 0.007 CID_7515 | CID_7515 | |
| 0.016 | 0.012 | 0.021 | Carbonic anhydrase X inhibitor | 0.021 0.007 CID_7515 | CID_7515 | |
| 0.021 | 0.017 | 0.021 | Geranylgeranyltransferase inhibitor | |||
| 0.031 | 0.027 | 0.033 | Vanilloid 4 antagonist | 0.033 0.022 CID_7515 | CID_7515 | |
| 0.024 | 0.02 | 0.024 | Sigma 1 receptor antagonist | |||
| 0.021 | 0.018 | 0.028 | Glutamate (mGluR1a) agonist | 0.028 0.01 CID_7515 | CID_7515 | |
| 0.019 | 0.016 | 0.019 | Toll-Like receptor 8 agonist | |||
| 0.033 | 0.03 | 0.033 | 5-Alpha-reductase inhibitor | |||
| 0.008 | 0.005 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 CID_7515 | CID_7515 | |
| 0.049 | 0.046 | 0.049 | Leukotriene B4 antagonist | |||
| 0.04 | 0.037 | 0.04 | Factor Xa inhibitor | |||
| 0.015 | 0.012 | 0.02 | Thromboxane A2 agonist | 0.02 0.006 CID_7515 | CID_7515 | |
| 0.036 | 0.034 | 0.036 | AMPA 4 receptor antagonist | |||
| 0.048 | 0.047 | 0.048 | Protein kinase C eta inhibitor | |||
| 0.024 | 0.023 | 0.026 | Complement factor 1r inhibitor | 0.026 0.017 CID_7515 | CID_7515 | |
| 0.062 | 0.06 | 0.062 | MAP kinase kinase 8 inhibitor | |||
| 0.048 | 0.046 | 0.052 | Nicotinic alpha7 receptor agonist | 0.052 0.04 CID_7515 | CID_7515 | |
| 0.048 | 0.047 | 0.066 | Nicotinic neuronal receptor agonist | 0.066 0.031 CID_7515 | CID_7515 | |
| 0.016 | 0.015 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.02 0.009 CID_7515 | CID_7515 | |
| 0.176 | 0.175 | 0.176 | Prostaglandin dehydrogenase inhibitor | |||
| 0.018 | 0.017 | 0.018 | Progesterone receptor B antagonist | |||
| 0.016 | 0.015 | 0.016 | Telomerase stimulant | |||
| 0.011 | 0.011 | 0.019 | Carbonic anhydrase XI inhibitor | 0.019 0.004 CID_7515 | CID_7515 | |
| 0.01 | 0.01 | 0.013 | Imidazoline I2 receptor antagonist | 0.013 0.005 CID_7515 | CID_7515 | |
| 0.03 | 0.03 | 0.033 | Glutamate (mGluR3) agonist | 0.033 0.02 CID_7515 | CID_7515 | |
| 0.029 | 0.03 | 0.051 | Calcium release-activated channel blocker | 0.051 0.009 CID_7515 | CID_7515 | |
| 0.017 | 0.018 | 0.019 | Alpha 2b adrenoreceptor agonist | 0.019 0.013 CID_7515 | CID_7515 | |
| 0.019 | 0.021 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 CID_7515 | CID_7515 | |
| 0.052 | 0.055 | 0.062 | Phosphodiesterase 1B inhibitor | 0.062 0.04 CID_7515 | CID_7515 | |
| 0.042 | 0.044 | 0.047 | Carbonic anhydrase XIV inhibitor | 0.047 0.036 CID_7515 | CID_7515 | |
| 0.024 | 0.027 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.024 CID_7515 | CID_7515 | |
| 0.042 | 0.045 | 0.046 | Adenosine A2b receptor antagonist | 0.046 0.038 CID_7515 | CID_7515 | |
| 0.036 | 0.039 | 0.051 | Carbonic anhydrase IV inhibitor | 0.051 0.024 CID_7515 | CID_7515 | |
| 0.022 | 0.026 | 0.025 | Lysine carboxypeptidase inhibitor | 0.025 0.022 CID_7515 | CID_7515 | |
| 0.043 | 0.047 | 0.048 | HCV NS3/NS4A protease inhibitor | 0.048 0.036 CID_7515 | CID_7515 | |
| 0.02 | 0.024 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.015 CID_7515 | CID_7515 | |
| 0.016 | 0.019 | 0.018 | Complement factor D inhibitor | 0.018 0.012 CID_7515 | CID_7515 | |
| 0.052 | 0.056 | 0.055 | Leukotriene C antagonist | 0.055 0.044 CID_7515 | CID_7515 | |
| 0.052 | 0.056 | 0.058 | Sphingosine kinase inhibitor | 0.058 0.043 CID_7515 | CID_7515 | |
| 0.021 | 0.026 | 0.025 | Glutamate (mGluR1) agonist | 0.025 0.016 CID_7515 | CID_7515 | |
| 0.039 | 0.044 | 0.046 | Potassium channel Kv1.3 blocker | 0.046 0.034 CID_7515 | CID_7515 | |
| 0.033 | 0.038 | 0.052 | Toll-Like receptor 2 agonist | 0.052 0.023 CID_7515 | CID_7515 | |
| 0.013 | 0.018 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.013 CID_7515 | CID_7515 | |
| 0.028 | 0.034 | 0.039 | Arginase inhibitor | 0.039 0.023 CID_7515 | CID_7515 | |
| 0.042 | 0.048 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.034 CID_7515 | CID_7515 | |
| 0.043 | 0.049 | 0.059 | mTOR inhibitor | 0.059 0.029 CID_7515 | CID_7515 | |
| 0.031 | 0.037 | 0.041 | Glutamate (mGluR3) antagonist | 0.041 0.019 CID_7515 | CID_7515 | |
| 0.182 | 0.188 | 0.222 | Thioredoxin glutathione reductase inhibitor | 0.222 0.154 CID_7515 | CID_7515 | |
| 0.038 | 0.044 | 0.041 | Glycine transporter inhibitor | 0.041 0.04 CID_7515 | CID_7515 | |
| 0.054 | 0.061 | 0.099 | I kappa B kinase 2 inhibitor | 0.099 0.013 CID_7515 | CID_7515 | |
| 0.059 | 0.066 | 0.063 | Prostaglandin-E synthase inhibitor | 0.063 0.058 CID_7515 | CID_7515 | |
| 0.041 | 0.048 | 0.068 | Ribonucleoside-diphosphate reductase inhibitor | 0.068 0.03 CID_7515 | CID_7515 | |
| 0.065 | 0.074 | 0.087 | Fibroblast growth factor 3 antagonist | 0.087 0.043 CID_7515 | CID_7515 | |
| 0.029 | 0.037 | 0.038 | Glutamate (mGluR4) agonist | 0.038 0.017 CID_7515 | CID_7515 | |
| 0.209 | 0.218 | 0.226 | DNA polymerase beta inhibitor | 0.226 0.207 CID_7515 | CID_7515 | |
| 0.028 | 0.037 | 0.043 | 5 Hydroxytryptamine 3B antagonist | 0.043 0.018 CID_7515 | CID_7515 | |
| 0.041 | 0.05 | 0.069 | Ribonucleotide reductase inhibitor | 0.069 0.031 CID_7515 | CID_7515 | |
| 0.072 | 0.081 | 0.076 | MAP kinase 7 inhibitor | 0.076 0.058 CID_7515 | CID_7515 | |
| 0.069 | 0.079 | 0.142 | I kappa B kinase inhibitor | 0.142 0.018 CID_7515 | CID_7515 | |
| 0.065 | 0.075 | 0.111 | Leucine-rich repeat kinase 2 inhibitor | 0.111 0.036 CID_7515 | CID_7515 | |
| 0.071 | 0.082 | 0.093 | Epidermal growth factor antagonist | 0.093 0.05 CID_7515 | CID_7515 | |
| 0.049 | 0.06 | 0.067 | Cyclin A2 inhibitor | 0.067 0.041 CID_7515 | CID_7515 | |
| 0.084 | 0.095 | 0.093 | Granulocyte macrophage colony stimulating factor antagonist | 0.093 0.081 CID_7515 | CID_7515 | |
| 0.035 | 0.046 | 0.039 | Sphingosine kinase 1 inhibitor | 0.039 0.033 CID_7515 | CID_7515 | |
| 0.017 | 0.029 | 0.039 | NMDA receptor glycine site antagonist | 0.039 0.009 CID_7515 | CID_7515 | |
| 0.048 | 0.06 | 0.061 | Sphingosine 1-phosphate receptor 3 antagonist | 0.061 0.037 CID_7515 | CID_7515 | |
| 0.045 | 0.057 | 0.055 | EphB4 antagonist | 0.055 0.044 CID_7515 | CID_7515 | |
| 0.103 | 0.116 | 0.114 | Protein kinase C nu inhibitor | 0.114 0.1 CID_7515 | CID_7515 | |
| 0.035 | 0.048 | 0.042 | Carbonic anhydrase VII inhibitor | 0.042 0.037 CID_7515 | CID_7515 | |
| 0.044 | 0.057 | 0.079 | 5 Hydroxytryptamine 3 antagonist | 0.079 0.025 CID_7515 | CID_7515 | |
| 0.035 | 0.05 | 0.059 | Dihydroorotase inhibitor | 0.059 0.017 CID_7515 | CID_7515 | |
| 0.027 | 0.042 | 0.041 | ATR kinase inhibitor | 0.041 0.012 CID_7515 | CID_7515 | |
| 0.044 | 0.061 | 0.052 | Fibroblast growth factor 4 antagonist | 0.052 0.05 CID_7515 | CID_7515 | |
| 0.026 | 0.042 | 0.041 | Nicotinic acid receptor agonist | 0.041 0.02 CID_7515 | CID_7515 | |
| 0.05 | 0.068 | 0.068 | Fibroblast growth factor 2 antagonist | 0.068 0.043 CID_7515 | CID_7515 | |
| 0.052 | 0.07 | 0.062 | Beta adrenoreceptor antagonist | 0.062 0.051 CID_7515 | CID_7515 | |
| 0.057 | 0.076 | 0.082 | Rho-associated kinase I inhibitor | 0.082 0.045 CID_7515 | CID_7515 | |
| 0.019 | 0.041 | 0.026 | 5 Hydroxytryptamine 4 agonist | 0.026 0.013 CID_7515 | CID_7515 | |
| 0.098 | 0.119 | 0.121 | Lipid peroxidase inhibitor | 0.121 0.093 CID_7515 | CID_7515 | |
| 0.03 | 0.052 | 0.075 | Purinergic P2Y antagonist | 0.075 0.014 CID_7515 | CID_7515 | |
| 0.025 | 0.047 | 0.032 | Carnitine palmitoyltransferase inhibitor | 0.032 0.027 CID_7515 | CID_7515 | |
| 0.041 | 0.063 | 0.054 | Beta 1 adrenoreceptor antagonist | 0.054 0.041 CID_7515 | CID_7515 | |
| 0.025 | 0.048 | 0.032 | Carnitine palmitoyltransferase 1 inhibitor | 0.032 0.027 CID_7515 | CID_7515 | |
| 0.042 | 0.066 | 0.062 | Cyclin A inhibitor | 0.062 0.042 CID_7515 | CID_7515 | |
| 0.014 | 0.038 | 0.022 | Alpha 1a adrenoreceptor agonist | 0.022 0.016 CID_7515 | CID_7515 | |
| 0.018 | 0.045 | 0.025 | Thyroid hormone agonist | 0.025 0.02 CID_7515 | CID_7515 | |
| 0.135 | 0.164 | 0.198 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.198 0.075 CID_7515 | CID_7515 | |
| 0.051 | 0.082 | 0.067 | Vanilloid antagonist | 0.067 0.059 CID_7515 | CID_7515 | |
| 0.049 | 0.081 | 0.158 | CDK1/cyclin B1 inhibitor | 0.158 0.014 CID_7515 | CID_7515 | |
| 0.043 | 0.076 | 0.054 | Cyclin A1 inhibitor | 0.054 0.051 CID_7515 | CID_7515 | |
| 0.035 | 0.068 | 0.05 | CDK4/cyclin D1 inhibitor | 0.05 0.049 CID_7515 | CID_7515 | |
| 0.087 | 0.12 | 0.175 | Lck kinase inhibitor | 0.175 0.052 CID_7515 | CID_7515 | |
| 0.054 | 0.089 | 0.059 | Prolactin release inhibitor | 0.059 0.055 CID_7515 | CID_7515 | |
| 0.043 | 0.082 | 0.053 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.046 CID_7515 | CID_7515 | |
| 0.114 | 0.153 | 0.124 | CC chemokine 6 receptor antagonist | 0.124 0.097 CID_7515 | CID_7515 | |
| 0.103 | 0.142 | 0.155 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.155 0.086 CID_7515 | CID_7515 | |
| 0.062 | 0.102 | 0.073 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.061 CID_7515 | CID_7515 | |
| 0.084 | 0.128 | 0.143 | CDK3/cyclin E inhibitor | 0.143 0.031 CID_7515 | CID_7515 | |
| 0.062 | 0.107 | 0.103 | Aurora-A kinase inhibitor | 0.103 0.064 CID_7515 | CID_7515 | |
| 0.087 | 0.133 | 0.118 | Vascular endothelial growth factor 3 antagonist | 0.118 0.096 CID_7515 | CID_7515 | |
| 0.082 | 0.13 | 0.119 | CDC-like kinase 3 inhibitor | 0.119 0.045 CID_7515 | CID_7515 | |
| 0.072 | 0.122 | 0.102 | Aurora-B kinase inhibitor | 0.102 0.08 CID_7515 | CID_7515 | |
| 0.036 | 0.089 | 0.068 | Phosphodiesterase 7A inhibitor | 0.068 0.013 CID_7515 | CID_7515 | |
| 0.121 | 0.174 | 0.143 | Death-associated protein kinase 3 inhibitor | 0.143 0.134 CID_7515 | CID_7515 | |
| 0.03 | 0.092 | 0.133 | Raf kinase C inhibitor | 0.133 0.017 CID_7515 | CID_7515 | |
| 0.075 | 0.137 | 0.109 | TRKA antagonist | 0.109 0.079 CID_7515 | CID_7515 | |
| 0.06 | 0.123 | 0.128 | Mediator release inhibitor | 0.128 0.041 CID_7515 | CID_7515 | |
| 0.05 | 0.114 | 0.116 | Platelet activating factor beta antagonist | 0.116 0.052 CID_7515 | CID_7515 | |
| 0.159 | 0.225 | 0.361 | Angiogenesis inhibitor | 0.361 0.067 CID_7515 | CID_7515 | |
| 0.035 | 0.102 | 0.044 | Phosphodiesterase 6C inhibitor | 0.044 0.042 CID_7515 | CID_7515 | |
| 0.077 | 0.144 | 0.118 | Tyrosine-protein kinase receptor antagonist | 0.118 0.088 CID_7515 | CID_7515 | |
| 0.117 | 0.187 | 0.166 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.166 0.109 CID_7515 | CID_7515 | |
| 0.007 | 0.077 | 0.021 | Purinergic P2Y1 antagonist | 0.021 0.008 CID_7515 | CID_7515 | |
| 0.056 | 0.127 | 0.093 | CDK2/cyclin A inhibitor | 0.093 0.064 CID_7515 | CID_7515 | |
| 0.039 | 0.112 | 0.067 | Glutamate receptor agonist | 0.067 0.066 CID_7515 | CID_7515 | |
| 0.043 | 0.12 | 0.08 | Rho-associated kinase II inhibitor | 0.08 0.045 CID_7515 | CID_7515 | |
| 0.082 | 0.16 | 0.143 | Histone deacetylase SIRT1 inhibitor | 0.143 0.068 CID_7515 | CID_7515 | |
| 0.096 | 0.178 | 0.124 | Papain-like protease (SARS coronavirus) inhibitor | 0.124 0.071 CID_7515 | CID_7515 | |
| 0.028 | 0.11 | 0.085 | CDK9/cyclin T1 inhibitor | 0.085 0.024 CID_7515 | CID_7515 | |
| 0.016 | 0.102 | 0.037 | DNA gyrase subunit B inhibitor | 0.037 0.028 CID_7515 | CID_7515 | |
| 0.137 | 0.224 | 0.191 | ErbB-1 antagonist | 0.191 0.1 CID_7515 | CID_7515 | |
| 0.047 | 0.134 | 0.094 | Fibroblast growth factor 1 antagonist | 0.094 0.063 CID_7515 | CID_7515 | |
| 0.048 | 0.135 | 0.086 | AXL receptor tyrosine kinase inhibitor | 0.086 0.052 CID_7515 | CID_7515 | |
| 0.037 | 0.125 | 0.057 | CDC25B inhibitor | 0.057 0.055 CID_7515 | CID_7515 | |
| 0.029 | 0.117 | 0.087 | Phosphodiesterase VII inhibitor | 0.087 0.02 CID_7515 | CID_7515 | |
| 0.021 | 0.11 | 0.037 | Antibiotic Aminoglycoside-like | 0.037 0.024 CID_7515 | CID_7515 | |
| 0.056 | 0.149 | 0.15 | Vascular endothelial growth factor antagonist | 0.15 0.054 CID_7515 | CID_7515 | |
| 0.072 | 0.17 | 0.178 | Tyrosine kinase inhibitor | 0.178 0.077 CID_7515 | CID_7515 | |
| 0.129 | 0.229 | 0.198 | MAP-kinase-activated kinase 5 inhibitor | 0.198 0.106 CID_7515 | CID_7515 | |
| 0.044 | 0.148 | 0.066 | Kallikrein 7 inhibitor | 0.066 0.037 CID_7515 | CID_7515 | |
| 0.043 | 0.154 | 0.137 | Vascular endothelial growth factor 2 antagonist | 0.137 0.053 CID_7515 | CID_7515 | |
| 0.067 | 0.193 | 0.163 | Src kinase inhibitor | 0.163 0.075 CID_7515 | CID_7515 | |
| 0.091 | 0.226 | 0.257 | Interleukin 6 antagonist | 0.257 0.022 CID_7515 | CID_7515 | |
| 0.033 | 0.179 | 0.102 | Cyclin-dependent kinase 1 inhibitor | 0.102 0.065 CID_7515 | CID_7515 | |
| 0.034 | 0.18 | 0.116 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.116 0.042 CID_7515 | CID_7515 | |
| 0.035 | 0.185 | 0.207 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.207 0.035 CID_7515 | CID_7515 | |
| 0.073 | 0.229 | 0.135 | Protein kinase (CK1) gamma 3 inhibitor | 0.135 0.107 CID_7515 | CID_7515 | |
| 0.052 | 0.207 | 0.12 | Interleukin 5 antagonist | 0.12 0.023 CID_7515 | CID_7515 | |
| 0.036 | 0.192 | 0.206 | I kappa B kinase 1 inhibitor | 0.206 0.005 CID_7515 | CID_7515 | |
| 0.039 | 0.199 | 0.089 | Vascular endothelial growth factor 1 antagonist | 0.089 0.074 CID_7515 | CID_7515 | |
| 0.028 | 0.202 | 0.157 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.157 0.031 CID_7515 | CID_7515 | |
| 0.031 | 0.205 | 0.071 | Protein kinase A inhibitor | 0.071 0.07 CID_7515 | CID_7515 | |
| 0.02 | 0.196 | 0.093 | Raf kinase inhibitor | 0.093 0.037 CID_7515 | CID_7515 | |
| 0.088 | 0.264 | 0.29 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.29 0.043 CID_7515 | CID_7515 | |
| 0.037 | 0.216 | 0.13 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.13 0.06 CID_7515 | CID_7515 | |
| 0.036 | 0.218 | 0.13 | Abl kinase inhibitor | 0.13 0.06 CID_7515 | CID_7515 | |
| 0.014 | 0.197 | 0.058 | Raf kinase B inhibitor | 0.058 0.043 CID_7515 | CID_7515 | |
| 0.057 | 0.264 | 0.115 | Protein kinase (CK1) gamma 1 inhibitor | 0.115 0.103 CID_7515 | CID_7515 | |
| 0.028 | 0.258 | 0.1 | c-Src kinase inhibitor | 0.1 0.089 CID_7515 | CID_7515 | |
| 0.097 | 0.331 | 0.206 | Cyclin-dependent kinase 3 inhibitor | 0.206 0.03 CID_7515 | CID_7515 | |
| 0.01 | 0.245 | 0.266 | Tyk2 inhibitor | 0.266 0.005 CID_7515 | CID_7515 | |
| 0.025 | 0.292 | 0.09 | Polo-like kinase-2 inhibitor | 0.09 0.035 CID_7515 | CID_7515 | |
| 0.078 | 0.356 | 0.169 | Death-associated protein kinase 1 inhibitor | 0.169 0.019 CID_7515 | CID_7515 | |
| 0.116 | 0.409 | 0.214 | Interleukin 2 agonist | 0.214 0.166 CID_7515 | CID_7515 | |
| 0.028 | 0.323 | 0.116 | TRKB antagonist | 0.116 0.078 CID_7515 | CID_7515 | |
| 0.013 | 0.326 | 0.06 | Check point kinase 1 inhibitor | 0.06 0.058 CID_7515 | CID_7515 | |
| 0.042 | 0.408 | 0.088 | Hematopoietic | 0.088 0.052 CID_7515 | CID_7515 | |
| 0.015 | 0.407 | 0.141 | Protein kinase B gamma inhibitor | 0.141 0.019 CID_7515 | CID_7515 | |
| 0.043 | 0.466 | 0.207 | Polo-like kinase-3 inhibitor | 0.207 0.041 CID_7515 | CID_7515 | |
| 0.006 | 0.461 | 0.048 | Factor VIIa inhibitor | 0.048 0.021 CID_7515 | CID_7515 | |
| 0.005 | 0.726 | 0.121 | DNA gyrase inhibitor | 0.121 0.013 CID_7515 | CID_7515 | |
| 0.029 | 0.769 | 0.143 | NOS3 expression enhancer | 0.143 0.08 CID_7515 | CID_7515 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |